Search Ontology:
ChEBI
osimertinib
- Term ID
- CHEBI:90943
- Synonyms
-
- AZD 9291
- AZD-9291
- AZD9291
- mereletinib
- N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide
- N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
- osimertinib
- osimertinibum
- Definition
- A member of the class of aminopyrimidines that is 4-(1-methylindol-3-yl)pyrimidin-2-amine in which one of the amino hydrogens is replaced by a 2-methoxy-4-[2-(dimethylamino)ethyl](methyl)amino-5-acrylamidophenyl group. Used (as the mesylate salt) for treatment of EGFR T790M mutation positive non-small cell lung cancer.
- References
-
- CAS:1421373-65-0
- DrugBank:DB09330
- Drug_Central:5062
- HMDB:HMDB0248778
- LINCS:LSM-6344
- PMID:26450446
- PMID:26515464
- PMID:26620497
- PMID:26720284
- PMID:26720671
- PMID:26729184
- PMID:29151359
- PMID:29782558
- PMID:29852038
- PMID:29999920
- PMID:30034220
- PMID:30126856
- PMID:30151614
- PMID:30153097
- PMID:30189719
- PMID:30194172
- PMID:30224350
- PMID:30358214
- PMID:30916819
- PMID:31446643
- PMID:32569688
- PMID:33163272
- PMID:33896242
- PMID:34303194
- PMID:34734065
- PMID:35015529
- PMID:35793806
- PMID:36031292
- PMID:36093451
- PMID:36104273
- PMID:36201715
- PMID:36210715
- PMID:36237272
- PMID:36258694
- PMID:36328480
- PMID:36354696
- PMID:36373445
- PMID:36420659
- PMID:36480925
- PMID:36527745
- PMID:36543437
- PMID:36544540
- PMID:36575215
- PMID:36578073
- PMID:36597021
- PMID:36638566
- PMID:37516900
- PMID:38115126
- Patent:WO2019138346
- Reaxys:23334373
- Wikipedia:Osimertinib
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from osimertinib
Phenotype where environments contain osimertinib
Phenotype modified by environments containing osimertinib
Human Disease Model